These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37760455)

  • 21. Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial.
    Gornick MC; Kurian AW; An LC; Fagerlin A; Jagsi R; Katz SJ; Hawley ST
    Cancer; 2018 Oct; 124(20):4000-4009. PubMed ID: 30289174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
    McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ
    Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usability testing of Avoiding Diabetes Thru Action Plan Targeting (ADAPT) decision support for integrating care-based counseling of pre-diabetes in an electronic health record.
    Chrimes D; Kitos NR; Kushniruk A; Mann DM
    Int J Med Inform; 2014 Sep; 83(9):636-47. PubMed ID: 24981988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Web-Based Cancer Self-Management Program (I-Can Manage) Targeting Treatment Toxicities and Health Behaviors: Human-Centered Co-design Approach and Cognitive Think-Aloud Usability Testing.
    Howell D; Bryant Lukosius D; Avery J; Santaguida A; Powis M; Papadakos T; Addario V; Lovas M; Kukreti V; Haase K; Mayo SJ; Papadakos J; Moradian S; Krzyzanowska MK
    JMIR Cancer; 2023 Jul; 9():e44914. PubMed ID: 37477968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants of prospectively demonstrated phenocopies in
    Dominguez-Valentin M; Evans DGR; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E
    Hered Cancer Clin Pract; 2018; 16():4. PubMed ID: 29371908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
    Momozawa Y; Sasai R; Usui Y; Shiraishi K; Iwasaki Y; Taniyama Y; Parsons MT; Mizukami K; Sekine Y; Hirata M; Kamatani Y; Endo M; Inai C; Takata S; Ito H; Kohno T; Matsuda K; Nakamura S; Sugano K; Yoshida T; Nakagawa H; Matsuo K; Murakami Y; Spurdle AB; Kubo M
    JAMA Oncol; 2022 Jun; 8(6):871-878. PubMed ID: 35420638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results of targeted sequencing of
    Saied MH; Elkaffash D; Fadl R; Haleem RA; Refeat A; Ibrahim I; Tahoun M; Elkayal A; Tayae E
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
    Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
    Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Globally Rare
    Oosthuizen J; Kotze MJ; Van Der Merwe N; Myburgh EJ; Bester P; van der Merwe NC
    Front Oncol; 2020; 10():619469. PubMed ID: 33643918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial communication and cascade testing among relatives of BRCA population screening participants.
    Lieberman S; Lahad A; Tomer A; Koka S; BenUziyahu M; Raz A; Levy-Lahad E
    Genet Med; 2018 Nov; 20(11):1446-1454. PubMed ID: 29595811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
    Mehemmai C; Cherbal F; Hamdi Y; Guedioura A; Benbrahim W; Bakour R; Abdelhak S
    Pathol Oncol Res; 2020 Apr; 26(2):715-726. PubMed ID: 30715675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
    Haddad JM; Robison K; Beffa L; Laprise J; ScaliaWilbur J; Raker CA; Clark MA; Hofstatter E; Dalela D; Brown A; Bradford L; Toland M; Stuckey A
    J Genet Couns; 2021 Dec; 30(6):1570-1581. PubMed ID: 33904624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
    Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
    J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usability Testing of an Internet-Based e-Counseling Platform for Adults With Chronic Heart Failure.
    Payne AY; Surikova J; Liu S; Ross H; Mechetiuc T; Nolan RP
    JMIR Hum Factors; 2015 May; 2(1):e7. PubMed ID: 27026267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
    Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
    Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers.
    Lee J; Ham JY; Park HY; Jung JH; Kim WW; Kang B; Chae YS; Lee SJ; Lee IH; Lee NY
    Sci Rep; 2022 Feb; 12(1):1842. PubMed ID: 35115620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
    Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
    Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.